(Q44236057)

1 December 2017

Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia (English)

1 reference

1 December 2017

0 references

0 references

1 reference

Marc Serfaty

1

1 reference

1 December 2017

Sandra Kennell-Webb

2

1 reference

1 December 2017

James Warner

3

1 reference

1 December 2017

Robert Blizard

4

1 reference

1 December 2017

Peter Raven

5

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

International Journal of Geriatric Psychiatry

1 December 2017

1 reference

1 December 2017

17

1 reference

1 December 2017

12

1 reference

1 December 2017

1120-1127

1 reference

The Relations among Caregiver Stress, “Sundowning” Symptoms, and Cognitive Decline in Alzheimer's Disease

1 December 2017

1 reference

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

A metaanalysis of controlled trials of neuroleptic treatment in dementia

21 January 2018

1 reference

How to do it. Get patients' consent to enter clinical trials

21 January 2018

1 reference

Melatonin as a therapeutic agent in the treatment of sleep disturbance in depression

21 January 2018

1 reference

Use of wrist activity for monitoring sleep/wake in demented nursing-home patients

21 January 2018

1 reference

7 January 2021

Melatonin: a new probe in psychiatric investigation?

1 reference

7 January 2021

Effect of melatonin in selected populations of sleep-disturbed patients.

1 reference

7 January 2021

Melatonin and jet lag: confirmatory result using a simplified protocol

1 reference

7 January 2021

Melatonin for treatment of sundowning in elderly persons with dementia - a preliminary study.

1 reference

7 January 2021

Automatic sleep/wake identification from wrist activity

1 reference

7 January 2021

Roadblocks encountered in recruiting patients for a study of sleep disruption in Alzheimer's disease.

1 reference

7 January 2021

1 reference

7 January 2021

Improvement of sleep quality in elderly people by controlled-release melatonin.

1 reference

7 January 2021

Melatonin replacement therapy of elderly insomniacs.

1 reference

7 January 2021

The treatment of sundowning. A selective review of pharmacological and nonpharmacological studies

1 reference

7 January 2021

Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking.

1 reference

7 January 2021

A double-blind trial of melatonin as a treatment for jet lag in international cabin crew.

1 reference

7 January 2021

Depression, anxiety, and sleep disturbances.

1 reference

7 January 2021

Entrainment of free-running circadian rhythms by melatonin in blind people

1 reference

7 January 2021

Daily rhythm of serum melatonin in patients with dementia of the degenerate type.

1 reference

7 January 2021

Actigraphic monitoring of movement and rest-activity rhythms in aging, Alzheimer's disease, and Parkinson's disease.

1 reference

7 January 2021

Identifiers

DOI

10.1002/GPS.760

1 reference

1 December 2017

1 reference